FOLH1 and neoplasm: However, absolute PSMA-positive tumor uptake continued to rise upon administration of higher dosages, going from 0.011 ± 0.002 nmol/g tumor (0.1 nmol injected dose) to 0.113 ± 0.012 nmol/g tumor (3 nmol injected dose, Figure S5).